Transduction of axotomized retinal ganglion cells by adenoviral vector administration at the optic nerve stump: an in vivo model system for the inhibition of neuronal apoptotic cell death

Citation
S. Kugler et al., Transduction of axotomized retinal ganglion cells by adenoviral vector administration at the optic nerve stump: an in vivo model system for the inhibition of neuronal apoptotic cell death, GENE THER, 6(10), 1999, pp. 1759-1767
Citations number
49
Categorie Soggetti
Molecular Biology & Genetics
Journal title
GENE THERAPY
ISSN journal
09697128 → ACNP
Volume
6
Issue
10
Year of publication
1999
Pages
1759 - 1767
Database
ISI
SICI code
0969-7128(199910)6:10<1759:TOARGC>2.0.ZU;2-R
Abstract
Axotomy of the rat optic nerve leads to apoptotic cell death of retinal gan glion cells (RGCs). We have used adenoviral vectors to transduce RGCs from the cut optic nerve stump, a paradigm in which only those neurons are trans duced which are directly affected by the axonal lesion. Transgenes encoded by the vectors were p35 and CrmA, which are potent intracellular anti-apopt otic proteins. We found :that p35. but not CrmA exerted significant rescue effects :;lon RGCs 14 days after axotomy. Expression of the transgenes was driven by the murine CMV (MCMV) promoter The respective mRNAs were detectab le 7 days but not 14 days after transduction. Since surviving RGCs were pre sent beyond the time-point of detectable transcription of the p35 transgene , we conclude that apoptosis has been efficiently inhibited. In addition, w e observed that transduction with two control vectors without a transgene i n El also resulted in a minor but significant RGC rescue, implicating neuro protective effects due to adenoviral transduction itself. This system will be useful in dissecting the pathways leading to neuronal cell death after a xonal lesions and in the evaluation of the important question whether the c ellular suicide program can be reverted to survival by therapeutic gene del ivery.